In 2024, global and US markets saw a slight increase in IPOs. Syntax Data used its FIS classification system to analyze the ...

The year 2025 is expected to see a resurgence of IPOs due to policy changes, monetary easing, and a favorable business ...

The U.S. IPO market is expected to see a blowout 2025, fueled by the return of business-friendly Donald Trump to the White ...

The tepid reception to Venture Global's ambitious valuation target shows companies need to set realistic expectations when ...

Liquefied natural gas exporter Venture Global said on Thursday it had raised $1.75 billion, marking the first big initial ...

Venture Global's shares were indicated to open up to 6% above their offer price in their debut on the New York Stock Exchange ...

As a result, Renaissance expects a banner year for IPOs, with an estimated volume range of 155 to 195 IPOs in 2025 and $40 ...

Drugs Made in America Acquisition (DMAAU) is a healthcare-focused blank check company raising $200.7M through IPO this week ...

It plans to open 14 new cafes in Malaysia and by 2026 and 2 more in Singapore this year. Read more at straitstimes.com.

Venture Global Inc. shares slipped 3.8% in the natural gas exporter’s debut as a public company, after slashing its price ...

Venture Global is the second-largest exporter of liquefied natural gas, or LNG, in the United States, and one of Trump's ...

The funds will support the development of Ascentage’s pipeline, including its lead candidate olverembatinib to treat blood ...